REQUEST A DEMO
Total
USD $0.00
Search more companies

Zuellig Pharma Corporation (Philippines)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Zuellig Pharma Corporation Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Zuellig Pharma Corporation is an enterprise based in Philippines. Its main office is in Paranaque. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on April 27, 1953. There are currently 1,392 (2024) people employed by Zuellig Pharma Corporation. The latest financial highlights indicate a net sales revenue increase of 3.92% in 2024. A growth of 10.77% was recorded in its total assets. The net profit margin of Zuellig Pharma Corporation increased by 0.04% in 2024.

Headquarters
Zuellig Pharma Building
Paranaque; National Capital Region; Postal Code: 1700

Contact Details: Purchase the Zuellig Pharma Corporation report to view the information.

Basic Information
Total Employees:
Purchase the Zuellig Pharma Corporation report to view the information.
Financial Auditors:
Purchase the Zuellig Pharma Corporation report to view the information.
Incorporation Date:
April 27, 1953
Key Executives
Purchase this report to view the information.
Chairman and Director
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Executive Vice President
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Zuellig Pharma Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
3.92%
Total Operating Revenue
3.89%
Operating Profit
-0.3%
EBITDA
-0.3%
Net Profit/Loss for the Period
6.75%
Total Assets
10.77%
Total Equity
9.46%
Operating Profit Margin
-0.09%
Net Profit Margin
0.04%
Return on Equity (ROE)
-0.43%
Debt / Equity
21.11%
Quick Ratio
-0.02%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?